Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 380

1.

Variability in lymph node irradiation in patients with breast cancer-results from a multi-center survey in German-speaking countries.

Borm KJ, Kessel K, Devecka M, Muench S, Straube C, Schiller K, Schüttrumpf L, Dapper H, Wöller B, Pigorsch S, Combs SE.

Strahlenther Onkol. 2019 Nov 13. doi: 10.1007/s00066-019-01537-3. [Epub ahead of print]

PMID:
31722060
2.

Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation.

Naumann P, Eberlein J, Farnia B, Liermann J, Hackert T, Debus J, Combs SE.

Cancers (Basel). 2019 Oct 26;11(11). pii: E1655. doi: 10.3390/cancers11111655.

PMID:
31717736
3.

Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy.

Vogel MME, Kessel KA, Schiller K, Devecka M, Gschwend JE, Weichert W, Wilkens JJ, Combs SE.

Radiat Oncol. 2019 Nov 11;14(1):198. doi: 10.1186/s13014-019-1391-0.

4.

Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.

Diehl CD, Shiban E, Straube C, Gempt J, Wilkens JJ, Oechsner M, Kessel C, Zimmer C, Wiestler B, Meyer B, Combs SE.

Cancer Commun (Lond). 2019 Nov 9;39(1):73. doi: 10.1186/s40880-019-0416-2.

5.

Post-neoadjuvant cellular dissociation grading based on tumour budding and cell nest size is associated with therapy response and survival in oesophageal squamous cell carcinoma.

Jesinghaus M, Boxberg M, Wilhelm D, Münch S, Dapper H, Quante M, Schlag C, Lange S, Budczies J, Konukiewitz B, Mollenhauer M, Schlitter AM, Becker KF, Feith M, Friess H, Steiger K, Combs SE, Weichert W.

Br J Cancer. 2019 Nov 6. doi: 10.1038/s41416-019-0623-2. [Epub ahead of print]

PMID:
31690830
6.

A proof of principle experiment for microbeam radiation therapy at the Munich compact light source.

Dombrowsky AC, Burger K, Porth AK, Stein M, Dierolf M, Günther B, Achterhold K, Gleich B, Feuchtinger A, Bartzsch S, Beyreuther E, Combs SE, Pfeiffer F, Wilkens JJ, Schmid TE.

Radiat Environ Biophys. 2019 Oct 26. doi: 10.1007/s00411-019-00816-y. [Epub ahead of print]

PMID:
31655869
7.

Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells.

Fischer JC, Bscheider M, Göttert S, Thiele Orberg E, Combs SE, Bassermann F, Heidegger S, Haas T, Poeck H.

Sci Rep. 2019 Oct 18;9(1):14955. doi: 10.1038/s41598-019-51431-2.

8.

Digital biomarkers: Importance of patient stratification for re-irradiation of glioma patients - Review of latest developments regarding scoring assessment.

Kessel KA, Combs SE.

Phys Med. 2019 Oct 14;67:20-26. doi: 10.1016/j.ejmp.2019.10.021. [Epub ahead of print]

PMID:
31622876
9.

Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922.

Kühnel A, Schilling D, Combs SE, Haller B, Schwab M, Multhoff G.

Cells. 2019 Sep 28;8(10). pii: E1166. doi: 10.3390/cells8101166.

10.

Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design.

Borm KJ, Oechsner M, Düsberg M, Buschner G, Weber W, Combs SE, Duma MN.

Radiother Oncol. 2019 Sep 17. pii: S0167-8140(19)33067-1. doi: 10.1016/j.radonc.2019.08.021. [Epub ahead of print]

PMID:
31540747
11.

MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease.

Mayinger M, Reibelt A, Borm KJ, Ettl J, Wilkens JJ, Combs SE, Oechsner M, Duma MN.

Radiat Oncol. 2019 Sep 18;14(1):170. doi: 10.1186/s13014-019-1380-3.

12.

Tumor grading of soft tissue sarcomas using MRI-based radiomics.

Peeken JC, Spraker MB, Knebel C, Dapper H, Pfeiffer D, Devecka M, Thamer A, Shouman MA, Ott A, von Eisenhart-Rothe R, Nüsslin F, Mayr NA, Nyflot MJ, Combs SE.

EBioMedicine. 2019 Oct;48:332-340. doi: 10.1016/j.ebiom.2019.08.059. Epub 2019 Sep 12.

13.

Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients.

Borm KJ, Schönknecht C, Nestler A, Oechsner M, Waschulzik B, Combs SE, Münch S, Niemeyer M, Duma MN.

BMC Cancer. 2019 Sep 11;19(1):907. doi: 10.1186/s12885-019-6104-4.

14.

Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation.

Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Vogel MME, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Eiber M, Mix M, la Fougère C, Christiansen H, Belka C, Combs SE, Grosu AL, Müller AC, Guckenberger M.

Eur Urol Focus. 2019 Sep 5. pii: S2405-4569(19)30270-6. doi: 10.1016/j.euf.2019.08.012. [Epub ahead of print]

PMID:
31495759
15.

Beam size limit for pencil minibeam radiotherapy determined from side effects in an in-vivo mouse ear model.

Sammer M, Teiluf K, Girst S, Greubel C, Reindl J, Ilicic K, Walsh DWM, Aichler M, Walch A, Combs SE, Wilkens JJ, Dollinger G, Schmid TE.

PLoS One. 2019 Sep 4;14(9):e0221454. doi: 10.1371/journal.pone.0221454. eCollection 2019.

16.

Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.

Lämmer F, Delbridge C, Würstle S, Neff F, Meyer B, Schlegel J, Kessel KA, Schmid TE, Schilling D, Combs SE.

PLoS One. 2019 Aug 20;14(8):e0221502. doi: 10.1371/journal.pone.0221502. eCollection 2019.

17.

[The risk of subsequent primary cancer after radiotherapy of localised prostate cancer with carbon ions may be reduced compared to treatment with photons].

Kraus KM, Combs SE.

Strahlenther Onkol. 2019 Nov;195(11):1033-1035. doi: 10.1007/s00066-019-01510-0. German. No abstract available.

PMID:
31420708
18.

Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique?

Mayinger M, Borm KJ, Dreher C, Dapper H, Duma MN, Oechsner M, Kampfer S, Combs SE, Habermehl D.

Radiat Oncol. 2019 Aug 1;14(1):135. doi: 10.1186/s13014-019-1328-7.

19.

Factors associated with the decline of psychological support in hospitalized patients with cancer.

Pichler T, Dinkel A, Marten-Mittag B, Hermelink K, Telzerow E, Ackermann U, Belka C, Combs SE, Gratzke C, Gschwend J, Harbeck N, Heinemann V, Herkommer K, Kiechle M, Mahner S, Pigorsch S, Rauch J, Stief C, Beckmann J, Heußner P, Herschbach P.

Psychooncology. 2019 Oct;28(10):2049-2059. doi: 10.1002/pon.5191. Epub 2019 Aug 16.

PMID:
31368613
20.

Stereotactic irradiation of the resection cavity after surgical resection of brain metastases - when is the right timing?

Scharl S, Kirstein A, Kessel KA, Diehl C, Oechsner M, Straube C, Meyer B, Zimmer C, Combs SE.

Acta Oncol. 2019 Aug 1:1-6. doi: 10.1080/0284186X.2019.1643917. [Epub ahead of print]

PMID:
31368403
21.

Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.

Dapper H, Schiller K, Münch S, Peeken JC, Borm K, Weber W, Combs SE.

BMC Cancer. 2019 Jul 29;19(1):742. doi: 10.1186/s12885-019-5970-0.

22.

A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers.

Straube C, Kessel KA, Zimmer C, Schmidt-Graf F, Schlegel J, Gempt J, Meyer B, Combs SE.

Curr Treat Options Oncol. 2019 Jul 19;20(9):71. doi: 10.1007/s11864-019-0673-y. Review.

PMID:
31324990
23.

Deep learning derived tumor infiltration maps for personalized target definition in Glioblastoma radiotherapy.

Peeken JC, Molina-Romero M, Diehl C, Menze BH, Straube C, Meyer B, Zimmer C, Wiestler B, Combs SE.

Radiother Oncol. 2019 Sep;138:166-172. doi: 10.1016/j.radonc.2019.06.031. Epub 2019 Jul 11.

PMID:
31302391
24.

Deep inspiration breath-hold for left-sided breast irradiation: Analysis of dose-mass histograms and the impact of lung expansion.

Oechsner M, Düsberg M, Borm KJ, Combs SE, Wilkens JJ, Duma MN.

Radiat Oncol. 2019 Jun 18;14(1):109. doi: 10.1186/s13014-019-1293-1.

25.

Selenium does not affect radiosensitivity of breast cancer cell lines.

Schilling D, Herold B, Combs SE, Schmid TE.

Radiat Environ Biophys. 2019 Aug;58(3):433-438. doi: 10.1007/s00411-019-00801-5. Epub 2019 Jun 14.

PMID:
31201502
26.

Definitive, intensity modulated tomotherapy with a simultaneous integrated boost for prostate cancer patients - Long term data on toxicity and biochemical control.

Schiller K, Geier M, Duma MN, Nieder C, Molls M, Combs SE, Geinitz H.

Rep Pract Oncol Radiother. 2019 Jul-Aug;24(4):315-321. doi: 10.1016/j.rpor.2019.05.004. Epub 2019 May 30.

PMID:
31193851
27.

Positive correlation between blood glucose and radiotherapy doses to the central gustatory system in Glioblastoma Multiforme patients.

Duma MN, Oszfolk NI, Boeckh-Behrens T, Oechsner M, Zimmer C, Meyer B, Pfluger PT, Combs SE.

Radiat Oncol. 2019 Jun 7;14(1):97. doi: 10.1186/s13014-019-1311-3.

28.

Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.

Eder T, Hess AK, Konschak R, Stromberger C, Jöhrens K, Fleischer V, Hummel M, Balermpas P, von der Grün J, Linge A, Lohaus F, Krause M, Baumann M, Stuschke M, Zips D, Grosu AL, Abdollahi A, Debus J, Belka C, Pigorsch S, Combs SE, Budach V, Tinhofer I; DKTK-ROG.

Eur J Cancer. 2019 Jul;116:67-76. doi: 10.1016/j.ejca.2019.04.015. Epub 2019 Jun 4.

PMID:
31173964
29.

Interfraction variation and dosimetric changes during image-guided radiation therapy in prostate cancer patients.

Fuchs F, Habl G, Devečka M, Kampfer S, Combs SE, Kessel KA.

Radiat Oncol J. 2019 Jun;37(2):127-133. doi: 10.3857/roj.2018.00514. Epub 2019 Mar 28.

30.

Application of presurgical navigated transcranial magnetic stimulation motor mapping for adjuvant radiotherapy planning in patients with high-grade gliomas.

Diehl CD, Schwendner MJ, Sollmann N, Oechsner M, Meyer B, Combs SE, Krieg SM.

Radiother Oncol. 2019 Sep;138:30-37. doi: 10.1016/j.radonc.2019.04.029. Epub 2019 May 25.

PMID:
31136960
31.

Acute Skin Damage and Late Radiation-Induced Fibrosis and Inflammation in Murine Ears after High-Dose Irradiation.

Dombrowsky AC, Schauer J, Sammer M, Blutke A, Walsh DWM, Schwarz B, Bartzsch S, Feuchtinger A, Reindl J, Combs SE, Dollinger G, Schmid TE.

Cancers (Basel). 2019 May 25;11(5). pii: E727. doi: 10.3390/cancers11050727.

32.

Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation.

Naumann P, Eberlein J, Farnia B, Hackert T, Debus J, Combs SE.

Cancers (Basel). 2019 May 23;11(5). pii: E709. doi: 10.3390/cancers11050709.

33.

Increased heat shock protein 70 (Hsp70) serum levels and low NK cell counts after radiotherapy - potential markers for predicting breast cancer recurrence?

Rothammer A, Sage EK, Werner C, Combs SE, Multhoff G.

Radiat Oncol. 2019 May 10;14(1):78. doi: 10.1186/s13014-019-1286-0.

34.

Neuroimaging for Radiation Therapy of Brain Tumors.

Popp I, Weber WA, Combs SE, Yuh WTC, Grosu AL.

Top Magn Reson Imaging. 2019 Apr;28(2):63-71. doi: 10.1097/RMR.0000000000000198. Review.

PMID:
31022049
35.

The Role of Particle Therapy for the Treatment of Skull Base Tumors and Tumors of the Central Nervous System (CNS).

Diehl CD, Halasz LM, Wilkens JJ, Grosu AL, Combs SE.

Top Magn Reson Imaging. 2019 Apr;28(2):49-61. doi: 10.1097/RMR.0000000000000197. Review.

PMID:
31022048
36.

MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma.

Spraker MB, Wootton LS, Hippe DS, Ball KC, Peeken JC, Macomber MW, Chapman TR, Hoff MN, Kim EY, Pollack SM, Combs SE, Nyflot MJ.

Adv Radiat Oncol. 2019 Feb 23;4(2):413-421. doi: 10.1016/j.adro.2019.02.003. eCollection 2019 Apr-Jun.

37.

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus.

Münch S, Pigorsch SU, Devečka M, Dapper H, Feith M, Friess H, Weichert W, Jesinghaus M, Braren R, Combs SE, Habermehl D.

Radiat Oncol. 2019 Apr 16;14(1):66. doi: 10.1186/s13014-019-1270-8.

38.

CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy.

Peeken JC, Bernhofer M, Spraker MB, Pfeiffer D, Devecka M, Thamer A, Shouman MA, Ott A, Nüsslin F, Mayr NA, Rost B, Nyflot MJ, Combs SE.

Radiother Oncol. 2019 Jun;135:187-196. doi: 10.1016/j.radonc.2019.01.004. Epub 2019 Apr 5.

PMID:
30961895
39.

[Radiosurgery and surgical neurovascular decompression are almost equal for treatment of trigeminal neuralgia].

Straube C, Shiban E, Meyer B, Combs SE.

Strahlenther Onkol. 2019 Jul;195(7):688-690. doi: 10.1007/s00066-019-01454-5. German. No abstract available.

PMID:
30949720
40.

Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference.

Lipkova J, Angelikopoulos P, Wu S, Alberts E, Wiestler B, Diehl C, Preibisch C, Pyka T, Combs SE, Hadjidoukas P, Van Leemput K, Koumoutsakos P, Lowengrub J, Menze B.

IEEE Trans Med Imaging. 2019 Aug;38(8):1875-1884. doi: 10.1109/TMI.2019.2902044. Epub 2019 Feb 27.

PMID:
30835219
41.

[Endocrine deficiency after radiotherapy of brain tumors in children and young adults].

Scharl S, Combs SE.

Strahlenther Onkol. 2019 May;195(5):450-452. doi: 10.1007/s00066-019-01442-9. German. No abstract available.

PMID:
30809690
42.

Cellular Dissociation Grading Based on the Parameters Tumor Budding and Cell Nest Size in Pretherapeutic Biopsy Specimens Allows for Prognostic Patient Stratification in Esophageal Squamous Cell Carcinoma Independent From Clinical Staging.

Jesinghaus M, Brühl F, Steiger K, Klare P, Reiser M, Scheiter A, Konukiewitz B, Kuhn P, Münch S, Quante M, Schmid RM, Wilhelm D, Feith M, Friess H, Combs SE, Saur D, Boxberg M, Weichert W.

Am J Surg Pathol. 2019 May;43(5):618-627. doi: 10.1097/PAS.0000000000001230.

PMID:
30807302
43.

Role of postoperative tumor volume in patients with MGMT-unmethylated glioblastoma.

Sales AHA, Bette S, Barz M, Huber T, Wiestler B, Ryang YM, Schmidt-Graf F, Liesche F, Combs SE, Meyer B, Gempt J.

J Neurooncol. 2019 May;142(3):529-536. doi: 10.1007/s11060-019-03124-z. Epub 2019 Feb 21.

PMID:
30790133
44.

Re-irradiation in elderly patients with glioblastoma: a single institution experience.

Straube C, Antoni S, Gempt J, Zimmer C, Meyer B, Schlegel J, Schmidt-Graf F, Combs SE.

J Neurooncol. 2019 Apr;142(2):327-335. doi: 10.1007/s11060-019-03101-6. Epub 2019 Jan 18.

PMID:
30659523
45.

ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery.

Wilke L, Andratschke N, Blanck O, Brunner TB, Combs SE, Grosu AL, Moustakis C, Schmitt D, Baus WW, Guckenberger M.

Strahlenther Onkol. 2019 Mar;195(3):193-198. doi: 10.1007/s00066-018-1416-x. Epub 2019 Jan 16. Review.

PMID:
30649567
46.

Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.

Peeken JC, Knie C, Kessel KA, Habermehl D, Kampfer S, Dapper H, Devecka M, von Eisenhart-Rothe R, Specht K, Weichert W, Wörtler K, Knebel C, Wilkens JJ, Combs SE.

Radiat Oncol. 2019 Jan 9;14(1):2. doi: 10.1186/s13014-019-1207-2.

47.

PET imaging in patients with brain metastasis-report of the RANO/PET group.

Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC.

Neuro Oncol. 2019 May 6;21(5):585-595. doi: 10.1093/neuonc/noz003.

PMID:
30615138
48.

Combining multimodal imaging and treatment features improves machine learning-based prognostic assessment in patients with glioblastoma multiforme.

Peeken JC, Goldberg T, Pyka T, Bernhofer M, Wiestler B, Kessel KA, Tafti PD, Nüsslin F, Braun AE, Zimmer C, Rost B, Combs SE.

Cancer Med. 2019 Jan;8(1):128-136. doi: 10.1002/cam4.1908. Epub 2018 Dec 18.

49.

CT-based dose recalculations in head and neck cancer radiotherapy: comparison of daily dose recalculations to less time-consuming approaches.

Wagenblast S, Kampfer S, Borm KJ, Combs SE, Pigorsch SU, Duma MN.

Strahlenther Onkol. 2019 Jun;195(6):475-481. doi: 10.1007/s00066-018-1406-z. Epub 2018 Dec 6.

PMID:
30523417
50.

Regeneration After Radiation- and Immune-Mediated Tissue Injury Is Not Enhanced by Type III Interferon Signaling.

Fischer JC, Lin CC, Heidegger S, Wintges A, Schlapschy M, Beudert M, Combs SE, Bassermann F, Skerra A, Haas T, Poeck H.

Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):970-976. doi: 10.1016/j.ijrobp.2018.11.038. Epub 2018 Nov 29.

PMID:
30503785

Supplemental Content

Loading ...
Support Center